Literature DB >> 8791779

Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism.

J A Goldstein1, J Blaisdell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8791779     DOI： 10.1016/s0076-6879(96)72025-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  30 in total

1.  Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood.

Authors:  Ersin Gumus; Ozgur Karaca; Melih O Babaoglu; Gökhan Baysoy; Necati Balamtekin; Hulya Demir; Nuray Uslu; Atilla Bozkurt; Aysel Yuce; Umit Yasar
Journal:  Eur J Clin Pharmacol       Date:  2011-11-11       Impact factor: 2.953

2.  Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers.

Authors:  Adriana Rocha; Eduardo B Coelho; Stefânia A Sampaio; Vera L Lanchote
Journal:  Br J Clin Pharmacol       Date:  2010-07       Impact factor: 4.335

3.  Genetic polymorphism of CYP2C19 in Maharashtrian population.

Authors:  Yogita Ghodke; Kalpana Joshi; Yashendra Arya; Anjali Radkar; Aditi Chiplunkar; Pooja Shintre; Bhushan Patwardhan
Journal:  Eur J Epidemiol       Date:  2007-11-03       Impact factor: 8.082

4.  Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.

Authors:  Nicole G Hunfeld; Ron A Mathot; Daan J Touw; Ron H van Schaik; Paul G Mulder; Paul F Franck; Ernst J Kuipers; William P Geus
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

5.  Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients.

Authors:  Mateusz Kurzawski; Barbara Gawrońska-Szklarz; Joanna Wrześniewska; Andrzej Siuda; Teresa Starzyńska; Marek Droździk
Journal:  Eur J Clin Pharmacol       Date:  2006-08-16       Impact factor: 2.953

6.  Impact of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir in patients with pancreatic cancer.

Authors:  Krishna Kattel; Ruby Evande; Chalet Tan; Goutam Mondal; Jean L Grem; Ram I Mahato
Journal:  Br J Clin Pharmacol       Date:  2015-06-11       Impact factor: 4.335

7.  Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment.

Authors:  M M Jukić; N Opel; J Ström; T Carrillo-Roa; S Miksys; M Novalen; A Renblom; S C Sim; E M Peñas-Lledó; P Courtet; A Llerena; B T Baune; D J de Quervain; A Papassotiropoulos; R F Tyndale; E B Binder; U Dannlowski; M Ingelman-Sundberg
Journal:  Mol Psychiatry       Date:  2016-11-29       Impact factor: 15.992

8.  Correlation of inter-individual variations of amitriptyline metabolism examined in hairs with CYP2C19 and CYP2D6 polymorphisms.

Authors:  Detlef Thieme; Burkhard Rolf; Hans Sachs; Dagmar Schmid
Journal:  Int J Legal Med       Date:  2007-11-09       Impact factor: 2.686

9.  Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects.

Authors:  Y S Pang; Y S Yang; L P Wong; T C Lee; A M Mustafa; Z Mohamed; Chim C Lang
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

10.  Investigation of the in vivo activity of CYP3A in Brazilian volunteers: comparison of midazolam and omeprazole as drug markers.

Authors:  Adriana Rocha; Eduardo B Coelho; Soraia A P Moussa; Vera L Lanchote
Journal:  Eur J Clin Pharmacol       Date:  2008-06-26       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.